Summary
Two fowlpox virus recombinants were constructed which expressed the host-protective antigen, VP 2, of infectious bursal disease virus (IBDV). Recombinant FPV-VP 2.4.3 contained the gene for the VP 2-VP 4-VP 3 polyprotein under the control of the vaccinia virus late promoter P.L 11 inserted within the thymidine kinase (TK) gene of FPV. In infected chicken embryo skin (CES) cells VP 2 and VP 3 proteins were correctly processed from the polyprotein precursor molecule. Recombinant FPV-VP 2 contained only the VP 2 encoding region under the control of the fowlpox early/late promoter P.E/L inserted immediately downstream of theTK gene. The expression level of VP 2 from FPV-VP 2 was approximately 5 times higher than from FPV-VP 2.4.3. Wing web inoculation of birds resulted in the development of typical fowlpox lesions and the development of antibodies to FPV with either of the recombinants, but only birds vaccinated with FPV-VP 2 developed antibodies to IBDV. When challenged with IBDV (strain 002-73), a significant level of protection was provided by FPV-VP 2 vaccination, although the level was lower than the protection provided by an oil adjuvanted inactivated whole IBDV vaccine. Birds vaccinated with FPV-VP 2.4.3 were not protected from infection as assessed by ELISA for the presence of IBD virus in bursae.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Azad AA, Barrett SA, Fahey KJ (1985) The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus. Virology 143: 35–44
Azad AA, Jagadish MN, Brown MA, Hudson PJ (1987) Deletion mapping and expression inEscherichia coli of the large genomic segment of a birnavirus. Virology 161: 145–152
Azad AA, McKern NM, Macreadie IG, Failla P, Heine H-G, Chapman A, Ward CW, Fahey KJ (1991) Physiochemical and immunological characterization of recombinant host-protective antigen (VP 2) of infectious bursal disease virus. Vaccine 9: 715–722
Bayliss CD, Spies U, Shaw K, Peters RW, Pagageorgiou A, Müller H, Boursnell MEG (1990) A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region of VP 2. J Gen Virol 71: 1303–1312
Bayliss CD, Peters RW, Cook JKA, Reece RL, Howes K, Binns MM, Boursnell MEG (1991) A recombinant fowlpox virus that expressed the VP 2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch Virol 120: 193–205
Becht H, Müller H, Müller HK (1988) Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J Gen Virol 69: 631–640
Boursnell MEG (1992) Avipoxvirus vectors. In: Binns MM, Smith GL (eds) Recombinant poxviruses. CRC Press, Boca Raton, pp 269–283
Boyle DB, Coupar BEH, Gibbs AJ, Seigman LJ, Both GW (1987) Fowlpox virus thymidine kinase: nucleotide sequence and relationships to other thymidine kinases. Virology 156: 355–365
Boyle DB, Coupar BEH (1988) A dominant selectable marker for the construction of recombinant poxviruses. Gene 65: 123–128
Boyle DB, Coupar BEH (1988) Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Res 10: 343–356
Brown F (1986) The classification and nomenclature of viruses: summary of results of meetings of the international committee on taxonomy of viruses in Sendai, September 1984. Intervirology 25: 141–143
Buller RML, Smith GL, Cremer K, Notkins AL, Moss B (1985) Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinasenegative phenotype. Nature 317: 813–815
Cheville NF (1967) Studies on the pathogenesis of Gumboro disease in the bursa of Fabricius, spleen and thymus of the chicken. Am J Pathol 51: 527–551
Coupar BEH, Teo T, Boyle DB (1990) Restriction endonuclease mapping of the fowlpox virus genome. Virology 179: 159–167
Dobos P, Hill PJ, Hallett R, Kells DTC, Becht H, Teninges D (1979) Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32: 593–605
Fahey KJ, O'Donnell IJ, Azad AA (1985) Characterization by Western blotting of the immunogens of infectious bursal disease virus. J Gen Virol 66: 1479–1488
Fahey KJ, Crooks JK, Fraser RA (1987) Assessment by ELISA of passively acquired protection against infectious bursal disease virus in chickens. Aust Vet J 64: 203–207
Fahey KJ, Erny K, Crooks J (1989) A conformational immunogen on VP 2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70: 1473–1481
Fahey KJ, McWaters P, Brown MA, Erny K, Murphy VJ, Hewish DR (1991) Virusneutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens. Avian Dis 35: 365–373
Heine H-G, Haritou M, Failla P, Fahey K, Azad A (1991) Sequence analysis and expression of the host-protective immunogen VP 2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. J Gen Virol 72: 1835–1843
Hudson PJ, McKern NM, Power BE, Azad AA (1986) Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acids Res 14: 5001–5012
Jackwood DH, Saif YM (1987) Antigenic diversity of infectious bursal disease viruses. Avian Dis 31: 766–770
Jagadish MN, Staton VJ, Hudson PJ, Azad AA (1988) Birnavirus precursor polyprotein is processed inEscherichia coli by its own virus-encoded polypeptide. J Virol 62: 1084–1087
Kibenge FSB, Dhillon AS, Russell RG (1988) Biochemistry and immunology of infectious bursal disease virus. J Gen Virol 69: 1757–1775
Kibenge FSB, Jackwood DJ, Mercado CC (1990) Nucleotide sequence analysis of genome segment A of infectious bursal disease virus. J Gen Virol 71: 569–577
Kumar S, Boyle DB (1990) A poxvirus bidirectional promoter element with early/late and late functions. Virology 179: 151–158
Lukert PD, Hitchner SB (1984) Infectious bursal disease. In: Hofstad MS (ed) Diseases of poultry, 8th edn. Iowa State University Press, Ames, pp 566–576
Macreadie IG, Vaughan PR, Chapman AJ, McKern NM, Jagadish MN, Heine H-G, Ward CW, Fahey KJ, Azad AA (1990) Passive protection against infectious bursal disease virus by viral VP 2 expressed in yeast. Vaccine 8: 549–552
Macreadie IG, Azad AA (1991) Internal initiation and frameshifting in infectious bursal disease virus sequence expressed inEscherichia coli. Virology 184: 773–776
Nazerian K, Lee LF, Yanagida N, Ogawa R (1992) Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J Virol 66: 1409–1413
Ogawa R, Yanagida N, Saeki S, Saito S, Ohkawa S, Gotoh H, Kodama K, Kamogawa K, Sawaguchi K, Iritani Y (1990) Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses. Vaccine 8: 486–490
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Snyder DB, Lana DP, Savage PK, Yancey FS, Mengel SA, Marquardt WW (1988) Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates. Avian Dis 32: 535–539
Stuart JC (1989) Acute infectious bursal disease in poultry. Vet Rec 125: 281
Taylor J, Edbauer C, Rey-Senelonge A, Bouquet J-F, Norton E, Goebel S, Desmettre P, Paoletti E (1990) Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J Virol 64: 1441–1450
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heine, HG., Boyle, D.B. Infectious bursal disease virus structural protein VP 2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Archives of Virology 131, 277–292 (1993). https://doi.org/10.1007/BF01378632
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01378632